المؤلفون: Pier Luigi Zinzani, Anna Sureda, Cecilia Carpio, Krimo Bouabdallah, Robin Meng, Guillaume Cartron, Marjolein van der Poel, Su-Peng Yeh, Raul Cordoba, Alessandro Re, Armando López-Guillermo, Lucie Lepine, Youngil Koh, Steven Le Gouill, Giovanni Abbadessa, Luís Francisco Araújo, Vincent Ribrag, Martine E D Chamuleau, Olivier Casasnovas, Ran Ji, Rao Saleem, Won Seog Kim, Maria Ilidia Moreira, Daniela Alves, Carmelo Carlo-Stella

المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Hematologie (9), Institut Català de la Salut, [Carlo-Stella C] Department of Biomedical Sciences, Humanitas University and Department of Oncology and Hematology, IRCCS Humanitas Research Hospital, Milano, Italy. [Zinzani PL] IRCCS Azienda Ospedaliero‐Universitaria di Bologna Istituto di Ematologia 'Seràgnoli' and Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università di Bologna, Bologna, Italy. [Sureda A] Institut Català D'Oncologia ‐ Hospital Duran i Reynals, IDIBELL, Universitat de Barcelona, Barcelona, Spain. [Araújo L] Universitário de Coimbra, Coimbra, Portugal. [Casasnovas O] Hématologie Clinique, CHU Dijon Bourgogne, Dijon, France. [Carpio C] Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus, Hematology, CCA - Cancer Treatment and quality of life, CCA - Cancer biology and immunology

المصدر: Hematological Oncology, 41(1), 108-119. Wiley
Scientia
Carlo-Stella, C, Zinzani, P L, Sureda, A, Araújo, L, Casasnovas, O, Carpio, C, Yeh, S-P, Bouabdallah, K, Cartron, G, Kim, W S, Cordoba, R, Koh, Y, Re, A, Alves, D, Chamuleau, M, le Gouill, S, López-Guillermo, A, Moreira, I, van der Poel, M W M, Abbadessa, G, Meng, R, Ji, R, Lépine, L, Saleem, R & Ribrag, V 2022, ' A phase 1/2, open-label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma ', Hematological Oncology . https://doi.org/10.1002/hon.3089
Hematological Oncology. John Wiley and Sons Ltd

مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, BONE-MARROW, Immunology, diffuse large B-cell lymphoma, Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Monoclonal::Antibodies, Monoclonal, Humanized [CHEMICALS AND DRUGS], Biochemistry, Gastroenterology, BRENTUXIMAB VEDOTIN, HODGKIN-LYMPHOMA, Hodgkin, Malaltia de - Tractament, Internal medicine, Phase (matter), MULTIPLE-MYELOMA, Medicine, Neoplasms::Neoplasms by Histologic Type::Lymphoma::Lymphoma, Non-Hodgkin::Lymphoma, T-Cell::Lymphoma, T-Cell, Peripheral [DISEASES], aminoácidos, péptidos y proteínas::proteínas::proteínas sanguíneas::inmunoproteínas::inmunoglobulinas::anticuerpos::anticuerpos monoclonales::anticuerpos monoclonales humanizados [COMPUESTOS QUÍMICOS Y DROGAS], In patient, Other subheadings::/therapeutic use [Other subheadings], peripheral T-cell lymphoma, CELL LYMPHOMA, Isatuximab, neoplasias::neoplasias por tipo histológico::linfoma::linfoma no Hodgkin::linfoma de células T::linfoma de células T periféricas [ENFERMEDADES], Anticossos monoclonals - Ús terapèutic, Otros calificadores::/uso terapéutico [Otros calificadores], business.industry, non-Hodgkin lymphoma, NIVOLUMAB, SAR650984, General Medicine, Cell Biology, Hematology, medicine.disease, neoplasias::neoplasias por tipo histológico::linfoma::enfermedad de Hodgkin [ENFERMEDADES], Lymphoma, CD38 EXPRESSION, Oncology, Multicenter study, Limfomes - Tractament, cemiplimab, Open label, business, Neoplasms::Neoplasms by Histologic Type::Lymphoma::Hodgkin Disease [DISEASES], isatuximab

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::086237dc28c03b5f031a7a993d237717
https://cris.maastrichtuniversity.nl/en/publications/5d163f18-ed7b-45ef-b334-d47a337fea84

المؤلفون: Sara A. Hurvitz, Maureen E. Trudeau, William J. Gradishar, Larisa Ryvo, Ming-Shen Dai, Sujith Kalmadi, Cristiano Souza, Eduardo Cronemberger, Suzette Delaloge, Adam Brufsky, Mafalda Oliveira, Vladimir Milovanov, Beverly Moy, Sung Bae Kim, Kiana Keyvanjah, J. Alarcón, Fairooz F. Kabbinavar, Ron Bose, Richard A. Bryce, Cristina Saura, Judith Bebchuk, Barbara Haley, Luciana Landeiro

المساهمون: Institut Català de la Salut, [Hurvitz SA] University of California Los Angeles/Jonsson Comprehensive Cancer Center, Los Angeles, California, USA. [Saura C, Oliveira M] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. SOLTI Breast Cancer Cooperative Group, Barcelona, Spain. [Trudeau ME] Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. [Moy B] Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA. [Delaloge S] Gustave Roussy, Villejuif, France, Vall d'Hebron Barcelona Hospital Campus

المصدر: The Oncologist
The oncologist, vol 26, iss 8
Scientia

مصطلحات موضوعية: 0301 basic medicine, Oncology, Central Nervous System, Cancer Research, Receptor, ErbB-2, Neoplasms::Neoplasms by Site::Breast Neoplasms [DISEASES], Neratinib, Other subheadings::Other subheadings::/drug therapy [Other subheadings], ErbB-2, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Cumulative incidence, Other subheadings::/therapeutic use [Other subheadings], Receptor, ErbB‐2, skin and connective tissue diseases, neoplasias::neoplasias por localización::neoplasias de la mama [ENFERMEDADES], Hazard ratio, terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Metastatic breast cancer, Treatment Outcome, 030220 oncology & carcinogenesis, Quinolines, Female, medicine.symptom, Receptor, medicine.drug, medicine.medical_specialty, Oncology and Carcinogenesis, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Breast Neoplasms, Lapatinib, Asymptomatic, Quimioteràpia combinada, Capecitabine, 03 medical and health sciences, Breast cancer, Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Internal medicine, Breast Cancer, medicine, Humans, Oncology & Carcinogenesis, Otros calificadores::/uso terapéutico [Otros calificadores], business.industry, medicine.disease, 030104 developmental biology, Central nervous system neoplasms, Mama - Càncer - Tractament, Avaluació de resultats (Assistència sanitària), business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5aa5727188c0b770c145eea2ece9e133
http://europepmc.org/articles/PMC8342591

المؤلفون: Lucía López Corral, Anna Sureda, Carlos Solano, Pau Abrisqueta, Juan-Manuel Sancho, Pere Barba, Guillermo Villacampa, Javier Briones, Rafael Hernani, Mi Kwon, Geltamo Spanish Groups Geth, Manuel Guerreiro, Gloria Iacoboni, José María Raya Sánchez, Alberto Mussetti, Ana Carolina Caballero, Alejandro Martin Garcia-Sancho, Juan Luis Reguera-Ortega, Rebeca Bailén, Nuria Martínez-Cibrian

المساهمون: Institut Català de la Salut, [Iacoboni G, Abrisqueta P, Barba P] Servei d’Hematologia, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Villacampa G] Oncology Data Science, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Martinez-Cibrian N] Department of Hematology, University Hospital Virgen del Rocio, Sevilla, Spain. [Bailén R] Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain. Gregorio Marañón Health Research Institute (IiSGM), Madrid, Spain. [Lopez Corral L] Hematology Department, Hospital Clínico Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain. Centro de Investigación del Cáncer-IBMCC, Salamanca, Spain. [Sanchez JM] Hematology Department, Hospital 12 de Octubre, Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Cancer Medicine
Dipòsit Digital de la UB
Universidad de Barcelona
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Iacoboni, Gloria Villacampa, Guillermo Martinez-Cibrian, Nuria Bailén, Rebeca Lopez-Corral, Lucia Sanchez, Jose M. Guerreiro, Manuel Caballero, Ana Carolina Mussetti, Alberto Sancho, Juan Manuel Hernani Morales, Rafael Abrisqueta, Pau Solano Vercet, Carlos Sureda, Anna Briones, Javier Martin Garcia-Sancho, Alejandro Kwon, Mi Reguera Ortega, Juan Luis Barba, Pere 2021 Real-World Evidence of Tisagenlecleucel for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma. Cancer Medicine 3214 3223
Scientia
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
RODERIC. Repositorio Institucional de la Universitat de Valéncia
Cancer Medicine, Vol 10, Iss 10, Pp 3214-3223 (2021)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Digital.CSIC. Repositorio Institucional del CSIC

مصطلحات موضوعية: Male, 0301 basic medicine, aminoácidos, péptidos y proteínas::proteínas::proteínas de membranas::receptores de superficie celular::receptores inmunológicos::receptores de antígenos::receptores de antígenos de linfocitos T [COMPUESTOS QUÍMICOS Y DROGAS], Cancer Research, non‐Hodgkin's lymphoma, Best Overall Response, hematological cancer, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Non- Hodgkin's lymphoma, Gastroenterology, 0302 clinical medicine, Medicine research, Other subheadings::/therapeutic use [Other subheadings], Càncer, B-cell lymphoma, RC254-282, Cancer, Original Research, Receptors, Chimeric Antigen, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, non‐, Standard of Care, Middle Aged, Patologia, Hodgkin&apos, Progression-Free Survival, Cytokine release syndrome, clinical cancer research, Oncology, neoplasias::neoplasias por tipo histológico::linfoma::linfoma no Hodgkin::linfoma de células B::linfoma de células B grandes difuso [ENFERMEDADES], 030220 oncology & carcinogenesis, Cytokines, Female, Lymphoma, Large B-Cell, Diffuse, non-Hodgkin's lymphoma, medicine.medical_specialty, Receptors, Antigen, T-Cell, Cèl·lules B - Tumors - Tractament, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Investigació mèdica, Real world evidence, 03 medical and health sciences, s lymphoma, Neoplasms::Neoplasms by Histologic Type::Lymphoma::Lymphoma, Non-Hodgkin::Lymphoma, B-Cell::Lymphoma, Large B-Cell, Diffuse [DISEASES], Refractory, clinical observations, Internal medicine, medicine, Humans, Radiology, Nuclear Medicine and imaging, Leukapheresis, Amino Acids, Peptides, and Proteins::Proteins::Membrane Proteins::Receptors, Cell Surface::Receptors, Immunologic::Receptors, Antigen::Receptors, Antigen, T-Cell [CHEMICALS AND DRUGS], Aged, Retrospective Studies, Otros calificadores::/uso terapéutico [Otros calificadores], business.industry, Teràpia cel·lular, Clinical Cancer Research, medicine.disease, Malaltia de Hodgkin, Non-Hodgkin's lymphoma, Lymphoma, 030104 developmental biology, Hodgkin's disease, Neoplasm Recurrence, Local, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc3ed43d4f70864e8d02a35098763901
https://doi.org/10.1002/cam4.3881

المؤلفون: Xavier Muñoz-Gall, Gijs van de Wetering, Shibing Yang, Andrea García, José Luis Izquierdo-Alonso, Francisco-Javier González-Barcala, Esther Mariscal

المساهمون: Institut Català de la Salut, [González-Barcala FJ] Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain. Respiratory Medicine, Universidad de Santiago de Compostela, Santiago de Compostela, Spain. [Muñoz-Gall X] Servei de Pneumologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. CIBER of Respiratory Diseases (CIBERes), Madrid, Spain. Departament de Biologia Cel•lular, Fisiologia i Immunologia, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Mariscal E, García A] GlaxoSmithKline, Madrid, Spain. [Yang S] GlaxoSmithKline, Collegeville, PA, USA. [van de Wetering G] Pharmerit International, Rotterdam, the Netherlands. [Izquierdo-Alonso JL] Medicine and Specialities Department, Universidad de Alcalá (Alcalá de Henares, Madrid), Hospital Universitario Guadalajara, Guadalajara, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: medicine.medical_specialty, Standard of care, Cost effectiveness, Cost-Benefit Analysis, Eosinophilic asthma, 03 medical and health sciences, 0302 clinical medicine, Adrenal Cortex Hormones, Internal medicine, Eosinophilia, economía y organizaciones para la atención de la salud::economía::costes y análisis de costes::análisis coste-beneficio [ATENCIÓN DE SALUD], medicine, hormonas, sustitutos de hormonas y antagonistas de hormonas::hormonas::hormonas de la corteza suprarrenal [COMPUESTOS QUÍMICOS Y DROGAS], Humans, Other subheadings::/therapeutic use [Other subheadings], Eosinofília, health care economics and organizations, enfermedades hematológicas y linfáticas::enfermedades hematológicas::trastornos leucocitarios::eosinofilia [ENFERMEDADES], Hormones, Hormone Substitutes, and Hormone Antagonists::Hormones::Adrenal Cortex Hormones [CHEMICALS AND DRUGS], Otros calificadores::/uso terapéutico [Otros calificadores], business.industry, 030503 health policy & services, Health Policy, Cost-effectiveness analysis, Asthma, Anti il 5, Hormones esteroides - Ús terapèutic, Health Care Economics and Organizations::Economics::Costs and Cost Analysis::Cost-Benefit Analysis [HEALTH CARE], Spain, 030220 oncology & carcinogenesis, Cost-eficàcia, Hemic and Lymphatic Diseases::Hematologic Diseases::Leukocyte Disorders::Eosinophilia [DISEASES], Quality-Adjusted Life Years, 0305 other medical science, business, Mepolizumab, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a3bb950255c8bbedde625844e331a59
https://doi.org/10.1080/13696998.2021.1941065

المؤلفون: Elias Jatem, Francisco Torres-Bondia, Bruno Montoro, Joan Lima, Alfons Segarra

المساهمون: Institut Català de la Salut, [Jatem E, Segarra A] Servicio de Nefrología, Hospital Arnau de Vilanova, Lleida, Spain. [Lima J] Servei de Medicina Interna, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Montoro B] Servei de Farmàcia Hospitalària, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Torres-Bondia F] Servicio de Farmacia Hospitalaria, Hospital Arnau de Vilanova, Lleida, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia
Kidney International Reports

مصطلحات موضوعية: medicine.medical_specialty, Atorvastatin, 030232 urology & nephrology, enfermedades urogenitales masculinas::enfermedades urológicas::enfermedades renales::nefrosis::síndrome nefrótico [ENFERMEDADES], Male Urogenital Diseases::Urologic Diseases::Kidney Diseases::Nephrosis::Nephrotic Syndrome [DISEASES], 030204 cardiovascular system & hematology, Gastroenterology, acciones y usos químicos::acciones farmacológicas::mecanismos moleculares de acción farmacológica::inhibidores enzimáticos [COMPUESTOS QUÍMICOS Y DROGAS], enfermedades nutricionales y metabólicas::enfermedades metabólicas::trastornos del metabolismo de los lípidos::dislipidemias::hiperlipidemias::hipercolesterolemia [ENFERMEDADES], 03 medical and health sciences, 0302 clinical medicine, Refractory, Clinical Research, Internal medicine, medicine, Hipercolesterolèmia - Complicacions, Inhibidors enzimàtics - Ús terapèutic - Eficàcia, Other subheadings::/therapeutic use [Other subheadings], Adverse effect, Proteinuria, hypercholesterolemia, biology, nephrotic syndrome, Otros calificadores::/uso terapéutico [Otros calificadores], business.industry, Vascular disease, PCSK9, dyslipidemia, Ronyons - Malalties, medicine.disease, PSCK9 inhibitors, Nephrology, Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors [CHEMICALS AND DRUGS], biology.protein, Creatine kinase, medicine.symptom, business, Nutritional and Metabolic Diseases::Metabolic Diseases::Lipid Metabolism Disorders::Dyslipidemias::Hyperlipidemias::Hypercholesterolemia [DISEASES], Nephrotic syndrome, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06040b30f10a2066f5d00a5210fe9207
https://doi.org/10.1016/j.ekir.2020.09.046

المؤلفون: Gloria Fraga, Jorge González, Neus Roca, A. Madrid, Elias Jatem, Cristina Martínez, Mercedes López, Alfons Segarra

المساهمون: Institut Català de la Salut, [Roca N] Servicio Nefrologia Pediátrica, Hospital Universitari de Vic, Universitat de Vic, Barcelona, Spain. [Madrid A] Servicio de Nefrología Pediátrica, Hospital de Sant Joan de Déu de Barcelona, Barcelona, Spain. [Lopez M] Servei de Nefrologia Pediàtrica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Fraga G] Servei de Nefrologia Pediàtrica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Servicio de Nefrología Pediátrica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. [Jatem E, Gonzalez J] Institut de Recerca Biomedica August Pi Sunyer, Lleida, Barcelona, Spain. Servicio de Nefrologia, Hospital Universitario Arnau de Vilanova, Lleida, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: CLINICAL KIDNEY JOURNAL
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Clinical Kidney Journal
Scientia
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau

مصطلحات موضوعية: Endotype, 030232 urology & nephrology, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Gastroenterology, 0302 clinical medicine, Focal segmental glomerulosclerosis, Other subheadings::/therapeutic use [Other subheadings], 030212 general & internal medicine, Hormones, Hormone Substitutes, and Hormone Antagonists::Hormones::Adrenal Cortex Hormones [CHEMICALS AND DRUGS], Proteinuria, medicine.diagnostic_test, biology, Haptoglobin, inflammatory response, endotypes, Nephrology, idiopathic nephrotic syndrome, Renal biopsy, medicine.symptom, Glomerulosclerosi - Tractament, medicine.medical_specialty, Corticosteroides - Ús terapèutic, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Renal function, 03 medical and health sciences, Cluster analysis, Idiopathic nephrotic syndrome, Internal medicine, Biopsy, medicine, hormonas, sustitutos de hormonas y antagonistas de hormonas::hormonas::hormonas de la corteza suprarrenal [COMPUESTOS QUÍMICOS Y DROGAS], AcademicSubjects/MED00340, enfermedades urogenitales masculinas::enfermedades urológicas::enfermedades renales::nefritis::glomerulonefritis::glomeruloesclerosis focal [ENFERMEDADES], Lymphocyte populations, focal segmental glomerulosclerosis, Transplantation, Otros calificadores::/uso terapéutico [Otros calificadores], lymphocyte populations, business.industry, Interleukins, Endotypes, Inflammatory response, Original Articles, medicine.disease, interleukins, SuPAR, Male Urogenital Diseases::Urologic Diseases::Kidney Diseases::Nephritis::Glomerulonephritis::Glomerulosclerosis, Focal Segmental [DISEASES], biology.protein, business, cluster analysis

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc51a52ce4f7be6ea3eda02081348d3e
https://doi.org/10.1093/ckj/sfaa265

المؤلفون: Rashmi Krishna Murthy, Amelia Zelnak, Giuseppe Curigliano, Carey K. Anders, Elisavet Paplomata, Mafalda Oliveira, Eric P. Winer, Virginia F. Borges, Karen A. Gelmon, Alison Conlin, Xuebei An, Michael DiGiovanna, Sibylle Loibl, Alicia Okines, Sara A. Hurvitz, Ruth O'Regan, Philippe L. Bedard, Andrew M Wardley, Lisa A. Carey, Thomas Bachelot, Jo Al Mayor, David Cameron, A. Jo Chien, Nan Lin, Sherene Loi, Vandana G. Abramson, Suzanne McGoldrick, Erika Hamilton, Volkmar Mueller

المساهمون: Institut Català de la Salut, [Lin NU] Dana-Farber Cancer Institute, Boston, MA, USA. [Borges V] University of Colorado Cancer Center, Aurora, CO, USA. [Anders C] Duke Cancer Institute, Durham, NC, USA. [Murthy RK] MD Anderson Cancer Center, Houston, TX, USA. [Paplomata E] Carbone Cancer Center/University of Wisconsin, Madison, WI, USA. [Hamilton E] Sarah Cannon Research Institute/Tennessee Oncology–Nashville, Nashville, TN, USA. [Oliveira M] Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Journal of Clinical Oncology
Scientia
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 38, iss 23
Lin, N U, Borges, V, Anders, C, Murthy, R K, Paplomata, E, Hamilton, E, Hurvitz, S, Loi, S, Okines, A, Abramson, V, Bedard, P L, Oliveira, M, Mueller, V, Zelnak, A, Digiovanna, M P, Bachelot, T, Chien, A J, O’regan, R, Wardley, A, Conlin, A, Cameron, D, Carey, L, Curigliano, G, Gelmon, K, Loibl, S, Mayor, J, Mcgoldrick, S, An, X & Winer, E P 2020, ' Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial ', Journal of Clinical Oncology, pp. JCO.20.00775 . https://doi.org/10.1200/JCO.20.00775, https://doi.org/10.1200/JCO.20.00775
BASE-Bielefeld Academic Search Engine

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, Pyridines, Receptor, ErbB-2, medicine.medical_treatment, Neoplasms::Neoplasms by Site::Breast Neoplasms [DISEASES], law.invention, ErbB-2, 0302 clinical medicine, Randomized controlled trial, Mama - Càncer, law, Trastuzumab, Antineoplastic Combined Chemotherapy Protocols, Other subheadings::/therapeutic use [Other subheadings], Young adult, Oxazoles, Cancer, neoplasias::neoplasias por localización::neoplasias de la mama [ENFERMEDADES], Brain Neoplasms, Middle Aged, 6.1 Pharmaceuticals, 030220 oncology & carcinogenesis, Disease Progression, Female, Receptor, medicine.drug, Adult, medicine.medical_specialty, Clinical Trials and Supportive Activities, Clinical Sciences, Oncology and Carcinogenesis, Breast Neoplasms, Capecitabine, 03 medical and health sciences, Young Adult, Breast cancer, Double-Blind Method, Clinical Research, Internal medicine, RAPID COMMUNICATIONS, Breast Cancer, medicine, Humans, Oncology & Carcinogenesis, terapéutica::protocolos clínicos::protocolos antineoplásicos::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Aged, Medicaments antineoplàstics - Ús terapèutic - Eficàcia, business.industry, Otros calificadores::/uso terapéutico [Otros calificadores], Neurosciences, Evaluation of treatments and therapeutic interventions, Therapeutics::Clinical Protocols::Antineoplastic Protocols::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], medicine.disease, Radiation therapy, 030104 developmental biology, Clinical research, Quinazolines, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d50a61cdbadd64177752d4282725713e
http://europepmc.org/articles/PMC7403000

المؤلفون: Catherine Leger, Toshihiko Doi, Kazuhiro Nishikawa, Aliaksandr Prokharau, Suayib Yalcin, David H. Ilson, C. Faustino, Takayuki Ando, Vera Gorbunova, Wasat Mansoor, Kohei Shitara, Donia Skanji, Javier Sabater, Nadia Amellal, Michele Ghidini, Eric Van Cutsem, Maria Alsina, Edvard Zhavrid, Josep Tabernero, Mikhail Dvorkin, Hendrik-Tobias Arkenau

المساهمون: Institut Català de la Salut, [Tabernero J, Alsina M] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. UVic-UCC, IOB-Quiron, Barcelona, Spain. [Shitara K, Doi T] National Cancer Center Hospital East, Chiba, Japan. [Dvorkin M] Omsk Regional Clinical Centre of Oncology, Omsk, Russia. [Mansoor W] The Christie NHS Foundation Trust, Manchester, UK, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia
Gastric Cancer

مصطلحات موضوعية: Male, Cancer Research, Pyrrolidines, Health-related quality of life, Medicaments antineoplàstics - Ús terapèutic, Trifluridine, tipiracil, Metastatic gastric cancer, chemistry.chemical_compound, Quality of life, Surgical oncology, Antineoplastic Combined Chemotherapy Protocols, Other subheadings::/therapeutic use [Other subheadings], ambiente y salud pública::salud pública::medidas epidemiológicas::demografía::estado de salud::calidad de vida [ATENCIÓN DE SALUD], Aged, 80 and over, Trifluridine/tipiracil, Gastroenterology, General Medicine, Middle Aged, Prognosis, humanities, Survival Rate, Oncology, Estómac - Càncer, Female, Original Article, Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Gastrointestinal Neoplasms::Stomach Neoplasms [DISEASES], Life Sciences & Biomedicine, Qualitat de vida - Avaluació, medicine.drug, Adult, MODULE, neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias gastrointestinales::neoplasias gástricas [ENFERMEDADES], medicine.medical_specialty, Adolescent, Adenocarcinoma, Phase 3, Placebo, Young Adult, Double-Blind Method, Stomach Neoplasms, Internal medicine, Post-hoc analysis, medicine, Humans, terapéutica::protocolos clínicos::protocolos antineoplásicos::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Aged, Tipiracil, Science & Technology, Gastroenterology & Hepatology, Otros calificadores::/uso terapéutico [Otros calificadores], business.industry, International Agencies, Therapeutics::Clinical Protocols::Antineoplastic Protocols::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Environment and Public Health::Public Health::Epidemiologic Measurements::Demography::Health Status::Quality of Life [HEALTH CARE], chemistry, Quality of Life, Gastric cancer, business, Thymine, Follow-Up Studies, Abdominal surgery

وصف الملف: application/pdf; Print-Electronic

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f279f17b20c298de80ea1c7855af538f
https://doi.org/10.1007/s10120-020-01053-9

المؤلفون: Luojun Victor Wang, Yvonne Y. Lau, Thomas John, Giovanni Selvaggi, Filippo de Braud, Jeffrey W. Scott, Enriqueta Felip, Vanessa Giannone, O. Alejandro Balbin, Michela Maur, Daniel Shao-Weng Tan, Pilar Cazorla, Martijn P. Lolkema, Herbert H. Loong, Johan Vansteenkiste, Alice T. Shaw, Jason Baum, Geoffrey Liu

المساهمون: Medical Oncology, Institut Català de la Salut, [Felip E] Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. [de Braud FG] University of Milan, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. [Maur M] AOU Policlinico of Modena, University of Modena and Reggio Emilia, Modena, Italy. [Loong HH] The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China. [Shaw AT] Massachusetts General Hospital, Boston, Massachusetts. [Vansteenkiste JF] University Hospital KU Leuven, Leuven, Belgium, Vall d'Hebron Barcelona Hospital Campus

المصدر: Journal of Thoracic Oncology, 15(3), 392-403. International Association for the Study of Lung Cancer
Scientia

مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Lung Neoplasms, medicine.medical_treatment, Ceritinib, NSCLC, Gastroenterology, Quimioteràpia combinada, 03 medical and health sciences, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Carcinoma, Non-Small-Cell Lung, Internal medicine, PD-1, Maculopapular rash, medicine, Humans, Anaplastic Lymphoma Kinase, Other subheadings::/therapeutic use [Other subheadings], Sulfones, Pulmons - Càncer - Quimioteràpia, Lung cancer, Adverse effect, nivolumab, Chemotherapy, Otros calificadores::/uso terapéutico [Otros calificadores], business.industry, terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms::Bronchial Neoplasms::Carcinoma, Bronchogenic::Carcinoma, Non-Small-Cell Lung [DISEASES], neoplasias::neoplasias por localización::neoplasias torácicas::neoplasias del tracto respiratorio::neoplasias pulmonares::neoplasias de los bronquios::carcinoma broncogénico::carcinoma de pulmón de células no pequeñas [ENFERMEDADES], medicine.disease, Rash, Nivolumab, Pyrimidines, 030104 developmental biology, ALK, Oncology, 030220 oncology & carcinogenesis, Cohort, medicine.symptom, business, medicine.drug

وصف الملف: application/pdf; Print-Electronic

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c585261ab269021e80247d15a18cb62
https://doi.org/10.1016/j.jtho.2019.10.006

المؤلفون: Weelden, W.J. van, Lalisang, R.I., Bulten, J., Lindemann, K., Beekhuizen, H.J. van, Trum, H., Boll, D., Werner, H.M.J., Lonkhuijzen, L.R.C.W. van, Yigit, R., Forsse, D., Witteveen, P.O., Galaal, K., Ginkel, A. van, Bignotti, E., Weinberger, V., Sweegers, S., Kroep, J.R., Cabrera, S., Snijders, M.P.L.M., Inda, M.A., Eriksson, A.G.Z., Krakstad, C., Romano, A., Stolpe, A. van de, Pijnenborg, J.M.A., European Network Individualized Tr

المساهمون: Gynecological Oncology, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), RS: GROW - R2 - Basic and Translational Cancer Biology, Obstetrie & Gynaecologie, MUMC+: MA Medische Staf Obstetrie Gynaecologie (9), Institut Català de la Salut, [van Weelden WJ] Department of Obstetrics and Gynaecology, Radboud Institute of Health Sciences, Radboud university medical center, Nijmegen, the Netherlands. [Lalisang RI] Division of Medical Oncology, Department of Internal Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands. GROW-School of Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, the Netherlands. [Bulten J] Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands. [Lindemann K] Division of Medicine, Department of Gynecological Oncology, Oslo University Hospital, Oslo, Norway. Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. [van Beekhuizen HJ] Department of Gynecologic Oncology, Erasmus MC Cancer Institute, Erasmus Medical Center Rotterdam, Rotterdam, the Netherlands. [Trum H] Center for Gynecologic Oncology Amsterdam, Netherlands Cancer Institute, Amsterdam, the Netherlands. [Cabrera S] Unitat d’Oncologia Ginecològica, Departament d'Obstetrícia i Ginecologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, CCA - Cancer Treatment and Quality of Life, Obstetrics and Gynaecology, CCA - Imaging and biomarkers, Targeted Gynaecologic Oncology (TARGON)

المصدر: American Journal of Obstetrics and Gynecology, 225(4), 407.e1-407.e16. Mosby Inc.
American Journal of Obstetrics and Gynecology
American Journal of Obstetrics and Gynecology, 225(4). MOSBY-ELSEVIER
Scientia
American Journal of Obstetrics and Gynecology, 225(4), 407.e1-407.e16. MOSBY-ELSEVIER
407.e1-407.e16
American Journal of Obstetrics and Gynecology, 225, 407.e1-407.e16
American Journal of Obstetrics and Gynecology, 225, 4, pp. 407.e1-407.e16
American journal of obstetrics and gynecology, 225(4), 407.e1-407.e16. Mosby Inc.
American Journal of Obstetrics and Gynecology, 225(4):407.e1-407.e16. MOSBY-ELSEVIER

مصطلحات موضوعية: Oncology, progestin therapy, acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antineoplásicos::antineoplásicos hormonales [COMPUESTOS QUÍMICOS Y DROGAS], Estrogen receptor, progesterone receptor, aromatase inhibitors, Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents::Antineoplastic Agents, Hormonal [CHEMICALS AND DRUGS], 0302 clinical medicine, Càncer - Recaiguda, Other subheadings::/therapeutic use [Other subheadings], 030212 general & internal medicine, estrogen receptor pathway activity, Otros calificadores::/terapia [Otros calificadores], Aged, 80 and over, 030219 obstetrics & reproductive medicine, Estrogen Antagonists, Obstetrics and Gynecology, Middle Aged, Immunohistochemistry, Progression-Free Survival, Women's cancers Radboud Institute for Health Sciences [Radboudumc 17], 3. Good health, Gene Expression Regulation, Neoplastic, ESTROGEN, Response Evaluation Criteria in Solid Tumors, Hormonal therapy, Female, Receptors, Progesterone, Carcinoma, Endometrioid, Endometri - Càncer - Hormonoteràpia, EXPRESSION, medicine.medical_specialty, Antineoplastic Agents, Hormonal, CARCINOMA, medicine.drug_class, Gynecologic oncology, 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, SDG 3 - Good Health and Well-being, Internal medicine, Progesterone receptor, Biomarkers, Tumor, medicine, Humans, RNA, Messenger, TAMOXIFEN, Aged, Otros calificadores::/uso terapéutico [Otros calificadores], business.industry, Endometrial cancer, Estrogen Receptor alpha, Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Genital Neoplasms, Female::Uterine Neoplasms::Endometrial Neoplasms [DISEASES], Other subheadings::/therapy [Other subheadings], medicine.disease, Confidence interval, Endometrial Neoplasms, MEDROXYPROGESTERONE ACETATE, ALPHA, Estrogen, Neoplasm Recurrence, Local, Progestins, neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias de los genitales femeninos::neoplasias uterinas::neoplasias endometriales [ENFERMEDADES], business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06d63ae01b4a199699440befab0f286a
https://pure.eur.nl/en/publications/bba017d5-9098-4a39-aec0-d65ac972dd69